Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime
ADVERTISEMENT
RECOMMENDED FOR YOU

Biocon Aims To Lead Copycat Wegovy Sales In Canada From Next Year


Bike Taxi Ban In Karnataka: Riders Hold Hunger Protest, Write Open Letter To CM

.png?rect=0%2C0%2C3500%2C1969&w=75)
Biocon To Use Rs 4,500-Crore QIP To Free Up Equity, Hike Stake In Subsidiary: CEO Mittal


VA Tech Wabag Targets 15-20% Revenue Growth Over Next Five Years
